Navigation Links
Daclizumab shows potential for new immunoregulatory approach to treating MS
Date:2/16/2010

bo, and is currently enrolling patients. The Phase 3 DECIDE trial is expected to be initiated in the second quarter of 2010.

About CHOICE

The CHOICE study is the first randomized, double-blind, placebo-controlled trial that evaluated the efficacy and safety of daclizumab (DAC) when added to IFNβ therapy. The study enrolled 230 patients, ages 18 to 55 years, with active relapsing MS who had an entry score of five or less on the Expanded Disability Status Scale (EDSS). The patients had to be taking a stable IFNβ regimen for a minimum of six months prior to enrollment. During the year prior to enrollment, patients had to have experienced at least one MS relapse or incurred at least one MS lesion of the brain or spinal cord while on a stable IFNβ regimen.

Patients remained on their baseline IFNβ regimens and were randomized in a ratio of 1:1:1 to three "add-on" treatment groups for 24 weeks: 2mg/kg daclizumab administered subcutaneously every two weeks (DAC high dose/ IFNβ); 1mg/kg daclizumab administered every four weeks (DAC low dose/ IFNβ); or placebo (placebo/ IFNβ).

The primary endpoint of the study was the total number of new or enlarged Gd-CELs measured monthly on brain MRI scans collected between weeks eight to 24. Additional endpoints included changes in the number and volume of lesions on TI- and T2-weighted MRIs, clinical relapse as assessed by the annualized relapse rate (ARR) and time to relapse, changes in EDSS and Multiple Sclerosis Functional Composite-3 (MSFC-3) scores, immunogenicity, pharmacokinetics (PK), pharmacodynamics (PD), clinical laboratory abnormalities and adverse events (AEs).

Compared with patients on placebo/IFNβ therapy alone, there was a 72 percent reduction in the number of new or enlarged Gd-CELs between weeks eight and 24 in the DAC high dose/IFNβ group (p=0.004, 95% CI 34%, 88%) and a 25 percent reduction in the DAC low dose/IFN&
'/>"/>

Contact: Kate Weiss
617-914-6524
GCI Health
Source:Eurekalert

Page: 1 2 3 4

Related biology technology :

1. Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
2. Mescal worm test shows DNA leaks into preservative liquids
3. Boost for Prostate Cancer Screening - Report Shows Mortality Reduction as High as 31%
4. Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy
5. UCBs Cimzia(R) (certolizumab pegol), Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid Arthritis
6. Tiny test tube experiment shows reaction of melting materials at the nano scale
7. New Survey Shows Devastating Impact of Rheumatoid Arthritis Pain on Intimate Relations
8. Topical erectile dysfunction therapy shows promise
9. Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost
10. Medicagos H1N1 pandemic vaccine candidate shows positive response in 100% of vaccinated animals after a single dose
11. Video shows nanotube spins as it grows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... The Latin American hardware encryption display market report defines ... and forecast of revenue. This market was valued at ... $2,366.8 million by 2018, at a CAGR of 70.3% ... of the Latin American hardware encryption market report to ... also provides a glimpse of the segmentation of the ...
(Date:10/19/2014)... 2014 The Asia-Pacific Bromine Market ... Asia-Pacific with analysis and forecast of revenue. , ... Bromine Market report, to get an idea of ... glimpse of the segmentation in the Asia-Pacific bromine ... figures. , http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html , Bromine ...
(Date:10/19/2014)... October 19, 2014 The report "Chocolate, ... Share, Trade, Prices, Geography Trend and Forecast (2011 - ... category, and geography and studies the major market drivers, ... America, Europe, and Asia. , The global chocolate market ... $98.3 billion in 2016 at an estimated CAGR of ...
(Date:10/19/2014)... According to market research report ... Controllers; Wireless gateways)]- Global Advancements, Forecasts and Analysis ... Outdoor Wi-Fi market with analysis and forecasting of ... identifies the drivers and the restrains for this ... and challenges. , Browse 65 market data tables ...
Breaking Biology Technology:The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 2The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 3The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 2Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 3Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 4Outdoor Wi-Fi Market (by Access Points, WLAN Controllers, Wireless gateways) Expected to Cross $37.2 Billion by 2018 - New Report by MarketsandMarkets 2Outdoor Wi-Fi Market (by Access Points, WLAN Controllers, Wireless gateways) Expected to Cross $37.2 Billion by 2018 - New Report by MarketsandMarkets 3Outdoor Wi-Fi Market (by Access Points, WLAN Controllers, Wireless gateways) Expected to Cross $37.2 Billion by 2018 - New Report by MarketsandMarkets 4
... Acquisition Provides Expanded Services to the Pharmaceutical and Biotech ... ... ANN ARBOR, Mich. and KIRKBYMOORSIDE, England, Sept. 10 /PRNewswire-,USNewswire/ ... public health protection, today,announced the acquisition of David Begg Associates ...
... BRIDGEWATER, Mass., Sept. 10 Pressure,BioSciences, Inc. (Nasdaq: ... the advantages of pressure cycling technology (PCT) in ... (2) detect,biomarkers of colon cancer, and (3) detect ... this week in three presentations at the 29th,Annual ...
... Development on the ... BURLINGTON, Mass., Sept. 10 Hyaluron Contract,Manufacturing (HCM), a ... pharmaceutical and biotechnology industries, announced,today that it has been ... Impact Award. HCM is one of five companies from ...
Cached Biology Technology:NSF International Acquires David Begg Associates 2Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Society's 29th Annual Meeting 2Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Society's 29th Annual Meeting 3Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist 2
(Date:10/14/2014)... discriminating thieves, prostate cancer tumors scavenge and hoard copper ... such avarice may be a fatal weakness. , ... kill prostate cancer cells by delivering a trove of ... diseased cells brimming with the mineral, leaving non-cancer cells ... already commercially available for other uses, could soon be ...
(Date:10/14/2014)... the planet,s leading questions is how to produce enough ... climate. The Food and Agriculture Organization of the United ... the next 40 years to feed a growing global ... necessary rise in food production. Plants—grains, cereals, fruits, ... livestock. Current research must tap into our knowledge ...
(Date:10/14/2014)... led by researchers at the University of Massachusetts ... Miller School of Medicine (UMMSM) have identified what ... (manic depressive) disorder, a breakthrough that could lead ... as well as depression and other related mood ... week in Nature Molecular Psychiatry , show ...
Breaking Biology News(10 mins):Prostate cancer's penchant for copper may be a fatal flaw 2Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3Rare genetic disease protects against bipolar disorder 2Rare genetic disease protects against bipolar disorder 3
... Engineering Conferences International (ECI) ( info@engconfintl.org ... XII Conference ( http://www.engconfintl.org/10ac.html ) are proud ... the winner of the 2010 Cell Culture ... Professor of Chemical and Biomolecular Engineering, at ...
... the Iberian Peninsula usually exceed the protection threshold established by ... according to data gathered between 2000 and 2005 by four ... Doana National Park. The limits established to protect human ... usually exceeded from April onwards, especially during the summer, in ...
... Langone Medical Center researchers have developed a powerful new method ... genes and examine how the process goes wrong in cancer ... research and described in the April 9 issue of ... DNA, a process required for gene activation. "The ...
Cached Biology News:Michael Betenbaugh wins 2010 Cell Culture Engineering award 2Ozone levels tend to be above recommended levels at this time of year in South West Spain 2Powerful new method allows scientists to probe gene activation 2
Bovine Calf Serum...
... This product is designed to deparaffinize and ... formalin fixed paraffin-embedded tissue sections mounted on ... melting the paraffin at the high temperature ... with emulsification of the paraffin by detergent. ...
Chicken polyclonal to ytzF ( Abpromise for all tested applications). Antigen: Full length protein...
NEWBORN CALF SERUM AND PLASMA...
Biology Products: